Humanized anti-CD25 monoclonal antibody replaces methotrexate as acute graft-versus-host disease prophylaxis in haploidentical allogeneic haematopoietic stem cell transplantation.

Br J Haematol · 2025 · PMC11829143 · PMID 39710371

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Grades I–II and II–IV aGVHD CI by day 100 showed no marked alteration between the two cohorts ( p = 0.158, p = 0.131); however, the double‐dose cohort showed a trend towards reduced CI (Figure 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.